Endothelium
Serum Response Factor Is Required for Sprouting Angiogenesis and Vascular Integrity
15/09/2008
Serum response factor (SRF) is a transcription factor
that controls the expression of cytoskeletal proteins
and immediate early genes in different cell types.
Here, we found that SRF expression is restricted to
endothelial cells (ECs) of small vessels such as
capillaries in the mouse embryo. EC-specific Srf
deletion led to aneurysms and hemorrhages from 11.5
days of mouse development (E11.5) and lethality at
E14.5. Mutant embryos presented a reduced capillary
density and defects in EC migration, with fewer
numbers of filopodia in tip cells and ECs showing
defects in actin polymerization and intercellular
junctions. We show that SRF is essential for the
expression of VE-cadherin and β-actin in ECs both in
vivo and in vitro. Moreover, knockdown of SRF in ECs
impaired VEGF- and FGF-induced in vitro angiogenesis.
Taken together, our results demonstrate that SRF
plays an important role in sprouting angiogenesis and
small vessel integrity in the mouse embryo.
Developmental Cell, Vol 15, 448-461, 16 September 2008
Developmental Cell, Vol 15, 448-461, 16 September 2008
|
Calcification of Multipotent Prostate Tumor Endothelium
08/09/2008
Solid tumors
require new blood vessels for growth and metastasis,
yet the biology of tumor-specific endothelial cells
is poorly understood. We have isolated tumor
endothelial cells from mice that spontaneously
develop prostate tumors. Clonal populations of tumor
endothelial cells expressed hematopoietic and
mesenchymal stem cell markers and differentiated to
form cartilage- and bone-like tissues. Chondrogenic
differentiation was accompanied by an upregulation of
cartilage-specific col2a1 and sox9, whereas
osteocalcin and the metastasis marker osteopontin
were upregulated during osteogenic differentiation.
In human and mouse prostate tumors, ectopic vascular
calcification was predominately luminal and
colocalized with the endothelial marker CD31. Thus,
prostate tumor endothelial cells are atypically
multipotent and can undergo a mesenchymal-like
transition.
Cancer Cell, Vol 14, 201-211, 09 September 2008
Cancer Cell, Vol 14, 201-211, 09 September 2008

